65,437 trials
Tuberculosis
Primary: Change in log10 Colony Forming Units (CFU) Per (/) Milliliter (mL) of Direct Respiratory Sputum Samples From Baseline to Day 14 — -0.199; -0.017; -0.092; -0.092…
Aging · Benzodiazepine Sedative Adverse Reaction · Anticholinergic Adverse Reaction
Primary: Change in Inappropriate Prescribing by Study Arm: Descriptive Comparison Across Study Arms — 35.2; 33; 35.6; 40.6 percentage of patients
Acute Kidney Injury
Primary: Number of Participants With Treatment-Emergent Adverse Events — 7; 7; 2; 1 Participants
Eosinophilic Esophagitis
Primary: Peak Esophageal Eosinophil Count — 57.3; 71.3 Peak # of eosinophils counted per field
Healthy Adult Volunteers
Primary: Average Palatability Rating — 3.5; 4.0; 4.9; 4.4 score on a scale out of 5
HIV/AIDS
Primary: CD4 Cell Count — 996; 1049 cells/mm^3
Cytomegalovirus (CMV) Infection · Kidney Transplantation
Primary: Number of Participants With Adverse Events and Serious Adverse Events — 6; 3; 23; 12 Participants
Colo-rectal Cancer
Primary: Overall Response Rate — 2; 5; 116; 116 Participants
Urinary Bladder Neoplasms
Primary: Number of Grades 1-5 Adverse Events — 12; 3; 15; 9 adverse events
Cardiac Arrest, Sudden
Primary: WCD False Positive Alarm Rate — 0.00075 false positive shock alarms per pt-day — p=<0.001
UGI Bleed · Upper Gastrointestinal Bleeding · Upper Gastrointestinal Bleed
Primary: Sensitivity — 26 Participants
Healthy Volunteers
Primary: Plasma Area Under the Curve (AUC) for Tenofovir Alafenamide (TAF) During the Dosing Interval of 0 to 24 Hours (AUC0-24hr) — 295.5; 472.1; 248.1 hr*ng/ml
Pilonidal Cysts
Primary: Healing Time — 78; 61 Days — p=0.094
Anesthesia, Local
Primary: The Proportion of Participants in Which an Eye Exam Was Able to be Performed — 30; 30 Participants
Arm Weakness as a Consequence of Stroke
Primary: Wolf Motor Function Test - Change in Functional Score by Task (WMFT) — 7; 3; 5 Tasks